Subscribe To
PMD / Psychemedics: 21% Sales Growth But Net Loss, Takeover Possibility, Covid Recovery Play
21% YoY revenue growth in Q4, gross margins surge 1,000 bps YoY. EPS loss of $0.29 on higher legal costs and a one-time expense.
Read More
Content Topics
Psychemedics
Sales
Growth
Loss
Takeover
Possibility
Covid
Psychemedics
Possibility
Recovery
Stock
PMD
Posted: Apr 25 2022, 15:46
Author Name: Seeking Alpha
Views: 111778
PMD News
By Seeking Alpha
April 25, 2022
Psychemedics: 21% Sales Growth But Net Loss, Takeover Possibility, Covid Recovery Play
21% YoY revenue growth in Q4, gross margins surge 1,000 bps YoY. EPS loss of $0.29 on higher legal costs and a one-time expense. more_horizontal